TOBRAMYCIN SULFATE - Food and Drug Administration
- Manufacturer
- Food and Drug Administration
- Effective date
- 2014-05-08
- Label type
- Indexing - Product Concept
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-05 00:15:48
Label at a glance#
ProductTOBRAMYCIN SULFATE
Active ingredientTOBRAMYCIN SULFATE
Products#
Every source-derived product name is available through these pages.
- TOBRAMYCIN SULFATE
- TOBRAMYCIN
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| TOBRAMYCIN SULFATE | HJT0RXD7JK | ACTIM |
| TOBRAMYCIN SULFATE | HJT0RXD7JK | ACTIM |
| TOBRAMYCIN SULFATE | HJT0RXD7JK | ACTIM |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tobramycin | TOBRAMYCIN SULFATE | Fresenius Kabi USA, LLC | 9a5cecd6-aa65-42d2-b15a-06b4fcebcc0f | 2024-02-07 | Boxed warning, Warnings, Adverse reactions | TOBRAMYCIN SULFATE |
| Tobramycin | TOBRAMYCIN SULFATE | Fresenius Kabi USA, LLC | d6dd9460-b030-479a-b3e3-03606e6fcad1 | 2024-02-05 | Boxed warning, Warnings, Adverse reactions | TOBRAMYCIN SULFATE |
| Tobramycin | TOBRAMYCIN SULFATE | Fresenius Kabi USA, LLC | d62ff359-912b-4be1-9fc2-2dde8777eefb | 2024-01-15 | Boxed warning, Warnings, Adverse reactions | TOBRAMYCIN SULFATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.